Smruthi Organics Limited

BSE:540686 Stock Report

Market Cap: ₹1.4b

Smruthi Organics Past Earnings Performance

Past criteria checks 0/6

Smruthi Organics's earnings have been declining at an average annual rate of -27%, while the Pharmaceuticals industry saw earnings growing at 13.5% annually. Revenues have been declining at an average rate of 1.1% per year.

Key information

-27.0%

Earnings growth rate

-26.9%

EPS growth rate

Pharmaceuticals Industry Growth17.5%
Revenue growth rate-1.1%
Return on equity-1.4%
Net Margin-0.8%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Smruthi Organics makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

BSE:540686 Revenue, expenses and earnings (INR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 241,198-91770
30 Jun 241,20041680
31 Mar 241,276361720
31 Dec 231,248281760
30 Sep 231,332521680
30 Jun 231,469611620
31 Mar 231,410411580
31 Dec 221,397481450
30 Sep 221,443821450
30 Jun 221,315821390
31 Mar 221,3341041370
31 Dec 211,2661181740
30 Sep 211,2181351710
30 Jun 211,2811671700
31 Mar 211,2651711180
31 Dec 201,2781591490
30 Sep 201,2691321420
30 Jun 201,280921330
31 Mar 201,311841360
31 Dec 191,419781540
30 Sep 191,500771480
30 Jun 191,416751400
31 Mar 191,374691290
31 Dec 181,26891870
30 Sep 181,100-11800
30 Jun 181,070-9990
31 Mar 18973-321720
31 Dec 1789134880
30 Sep 1786226850
30 Jun 1777212810
31 Mar 1779416790
31 Dec 1679318800
30 Sep 167756770
30 Jun 1675311760
31 Mar 167267750
31 Dec 1575218912
30 Sep 157150832
30 Jun 15656-28762
31 Mar 15748-38630
31 Dec 14761-85774
30 Sep 14829-92884
30 Jun 14953-66850
31 Mar 14918-621014
31 Dec 13831-681079

Quality Earnings: 540686 is currently unprofitable.

Growing Profit Margin: 540686 is currently unprofitable.

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: 540686 is unprofitable, and losses have increased over the past 5 years at a rate of 27% per year.

Accelerating Growth: Unable to compare 540686's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: 540686 is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (20.5%).

Return on Equity

High ROE: 540686 has a negative Return on Equity (-1.36%), as it is currently unprofitable.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/30 09:08
End of Day Share Price 2024/12/30 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Smruthi Organics Limited is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Kameswari V. S. ChavaliFirstCall Research